Mould meningitis associated with intravenous drug use

Hassan Shah1, Stephen Honeybul2, Stephanie Tang1

  • 1Department of Rehabilitation Medicine, Fiona Stanley Hospital, Perth, Western Australia, Australia.

Insights

This rare case study details mould meningitis in an immunocompetent patient, likely from intravenous drug use. It emphasizes the low sensitivity of cerebrospinal fluid (CSF) cultures for diagnosing fungal infections.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Mycology

Background:

  • Fungal meningitis is typically caused by Cryptococcus species and dimorphic fungi.
  • Mould meningitis is a rare but serious fungal infection affecting the central nervous system.

Purpose of the Study:

  • To report a rare case of mould meningitis, ventriculitis, and subependymal nodules in an immunocompetent individual.
  • To highlight diagnostic challenges and potential routes of infection in fungal meningitis.

Main Methods:

  • Case report presentation.
  • Review of clinical presentation, diagnostic procedures, and treatment.
  • Discussion of diagnostic limitations and alternative approaches.

Main Results:

  • A rare case of mould meningitis, ventriculitis, and subependymal nodules was observed in an immunocompetent patient.
  • Intravenous drug use was identified as the likely source of infection seeding the meninges and ventricular system.
  • The specific causative mould species remained undetermined.
  • Cerebrospinal fluid (CSF) culture demonstrated poor sensitivity in identifying the fungal pathogen.

Conclusions:

  • The case underscores the diagnostic difficulties associated with mould meningitis.
  • Surgical biopsy should be considered in cases of diagnostic uncertainty where fungal infection is suspected.
  • Further research into sensitive diagnostic methods for fungal meningitis is warranted.

Related Concept Videos

Cranial and Spinal Meninges01:19

Cranial and Spinal Meninges

The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
4.1K
Imaging Studies V: Intravenous Urography and Retrograde Pyelography01:22

Imaging Studies V: Intravenous Urography and Retrograde Pyelography

IntroductionIntravenous Urography (IVU) and Retrograde Pyelography (RP) are important diagnostic imaging techniques used to evaluate the urinary system. These methods help identify structural abnormalities, obstructions, and functional issues in the kidneys, ureters, and bladder. Both procedures use iodine-based contrast media to enhance the visibility of urinary tract structures on X-ray images, though they differ in their methods and indications.1. Intravenous Urography (IVU)Intravenous...
1.5K
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia01:16

Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia

Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
1.4K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
448
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
162
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
270